arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Pharvaris N.V.

PHVS Health Care Biotechnology: Pharmaceutical Preparations
$35.25
Today
as of Sep 4, 16:53 ET
Last 30 days +3.77% Jul 27 → Sep 04
$31.85 $33.31 $34.78 $36.25 $37.71 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$35.36
High
$36.39
Low
$35.21
Volume
$483,513
Avg Vol
$331,134
Mkt Cap
$2.5B
P/E (TTM)
—
Beta
—
52w High
$38.13
52w Low
$20.65
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 11 items

Sep 3 · 10:50 PR GlobeNewswire
Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026
Aug 13 · 16:18 MT Newswires
Pharvaris Could See Significant Upside on Positive Phase 3 Data, RBC Says
Aug 13 · 10:51 MT Newswires
RBC Adjusts PT on Pharvaris to $52 From $51, Maintains Outperform Speculative Risk Rating
▸ Show all 11 press releases & news Free account →

Overview

52-week range
$21
$38
84% of range
Avg surprise (last 3)
-3.8%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
185%
EM ±28.9% · $35 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.94$-0.88$-0.82$-0.76$-0.70 Actual $-0.89Est $-0.80Actual $-0.94Est $-0.87Actual $-0.70Est $-0.76 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.70 $-0.76 +7.9% +21.4% +4.3% earnings
Tue Aug 12, 2025Jun/2025 $-0.94 $-0.87 -8.1% — — earnings
Tue May 13, 2025Mar/2025 $-0.89 $-0.80 -11.2% — -4.2% earnings

Implied volatility — last 90 days

58%136%213%290%368% Jun 08 — IV 120% · EM ±15.8%Jun 09 — IV 126% · EM ±15.8%Jun 11 — IV 152% · EM ±16.8%Jun 12 — IV 159% · EM ±16.3%Jun 15 — IV 221% · EM ±16.0%Jun 19 — IV 99% · EM ±22.0%Jun 22 — IV 120% · EM ±25.1%Jun 23 — IV 97% · EM ±19.8%Jun 24 — IV 96% · EM ±19.3%Jun 25 — IV 91% · EM ±17.8%Jun 26 — IV 93% · EM ±17.9%Jun 29 — IV 97% · EM ±17.2%Jun 30 — IV 59% · EM ±10.1%Jul 01 — IV 101% · EM ±16.9%Jul 02 — IV 84% · EM ±13.5%Jul 03 — IV 86% · EM ±13.5%Jul 06 — IV 77% · EM ±10.7%Jul 07 — IV 104% · EM ±13.7%Jul 08 — IV 68% · EM ±8.5%Jul 09 — IV 76% · EM ±9.0%Jul 10 — IV 110% · EM ±12.1%Jul 13 — IV 143% · EM ±11.9%Jul 14 — IV 156% · EM ±11.3%Jul 15 — IV 123% · EM ±7.3%Jul 16 — IV 368% · EM ±15.4%Jul 20 — IV 74% · EM ±17.4%Jul 21 — IV 93% · EM ±21.6%Jul 22 — IV 95% · EM ±21.7%Jul 23 — IV 100% · EM ±22.4%Jul 24 — IV 100% · EM ±22.1%Jul 27 — IV 102% · EM ±21.3%Jul 28 — IV 102% · EM ±21.0%Jul 29 — IV 114% · EM ±22.9%Jul 30 — IV 111% · EM ±21.7%Jul 31 — IV 147% · EM ±28.1%Aug 03 — IV 165% · EM ±29.3%Aug 04 — IV 134% · EM ±23.0%Aug 05 — IV 138% · EM ±23.0%Aug 06 — IV 119% · EM ±19.3%Aug 07 — IV 113% · EM ±17.7%Aug 10 — IV 116% · EM ±16.0%Aug 11 — IV 120% · EM ±15.9%Aug 12 — IV 129% · EM ±16.2%Aug 13 — IV 145% · EM ±17.1%Aug 14 — IV 129% · EM ±14.2%Aug 17 — IV 169% · EM ±14.2%Aug 18 — IV 195% · EM ±14.1%Aug 20 — IV 109% · EM ±4.5%Aug 24 — IV 122% · EM ±25.5%Aug 25 — IV 132% · EM ±27.0%Aug 26 — IV 134% · EM ±26.9%Aug 27 — IV 134% · EM ±26.2%Aug 28 — IV 148% · EM ±28.3%Aug 31 — IV 171% · EM ±30.3%Sep 01 — IV 169% · EM ±29.1%Sep 02 — IV 171% · EM ±28.6%Sep 03 — IV 154% · EM ±24.9%Sep 04 — IV 185% · EM ±28.9%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in